Table 2 Laboratory examinations and echocardiographic characteristics of thrombosis group and control group
|  | Total (n = 472) | LAT /LASEC group (n = 80) | Non-LAT/LASEC group (n = 392) | P value |
|---|---|---|---|---|
Laboratory examinations | ||||
 Hb (g/l) | 133.8 ± 17.8 | 130.7 ± 13.1 | 134.0 ± 18.6 | 0.049* |
 Plt (*10^9/l) | 186.9 ± 61.6 | 183.0 ± 54.3 | 187.7 ± 63.2 | 0.576 |
 ALT(U/L) | 28.6 ± 61.0 | 22.6 ± 21.1 | 30.0 ± 66.7 | 0.361 |
 AST(U/L) | 29.7 ± 75.7 | 24.1 ± 13.8 | 30.9 ± 83.9 | 0.508 |
 sCr (mmol/l) | 81.3 ± 25.0 | 85.7 ± 24.8 | 80.2 ± 25.0 | 0.102 |
 BUN (mmol/l) | 6.3 ± 2.1 | 5.7 ± 1.7 | 6.2 ± 2.1 | 0.167 |
 D-Dimer | 0.53 ± 1.67 | 0.48 ± 0.43 | 0.54 ± 1.62 | 0.700 |
Transthoracic echocardiographic parameters | ||||
 LAD (mm) | 45.2 ± 6.8 | 48.1 ± 7.5 | 44.6 ± 6.5 | < 0.001* |
 LVESD (mm) | 30.6 ± 5.6 | 31.6 ± 5.3 | 30.4 ± 5.6 | 0.092 |
 LVEDD (mm) | 47.4 ± 5.0 | 47.5 ± 5.1 | 47.3 ± 4.5 | 0.755 |
 IVsT (mm) | 9.96 ± 1.98 | 10.67 ± 3.00 | 9.79 ± 1.67 | 0.018* |
 LVPWT (mm) | 9.58 ± 1.60 | 10.26 ± 2.44 | 9.42 ± 1.33 | 0.418 |
 LVEF (%) | 63.0 ± 9.0 | 60.3 ± 9.3 | 63.5 ± 8.8 | 0.005* |
 Pulmonary artery pressure (mmHg) | 28.6 ± 8.5 | 30.9 ± 9.8 | 28.1 ± 8.2 | 0.011* |
Transesophageal echocardiographic parameters | ||||
 LAD (mm) | 47.6 ± 7.3 | 52.2 ± 6.2 | 46.7 ± 7.1 | < 0.001* |
 Lobes of Left atrial appendage | 1.32 ± 0.58 | 1.67 ± 0.77 | 1.25 ± 0.50 | <0.001* |
 1 (n, %) | 289 (61.2%) | 47 (41.3%) | 242 (78.3%) | < 0.001* |
 2 (n, %) | 83 (17.6%) | 25 (31.3%) | 58 (18.8%) | |
 > = 3 (n, %) | 17 (3.6%) | 8 (10.0%) | 9 (2.9%) | |
 LUPVFV (m/s) | 0.63 ± 0.24 | 0.54 ± 0.17 | 0.67 ± 0.26 | 0.03* |
 LAAFV (m/s) | 0.35 ± 0.19 | 0.31 ± 0.13 | 0.37 ± 0.20 | 0.217 |
 PFO (n, %) | 33 (7.0%) | 7 (8.8%) | 26 (6.6%) | 0.532 |